B6.MRL/lpr display a chronic pro-inflammatory microenvironment at vascular barriers. Inhibition of S1P Receptor signaling is efficacious in attenuating injury in the B6.MRL/lpr strain. A shift from S1P1 to S1P2 usage by vascular endothelium is detected in the B6.MRL/lpr strain.